Not yet recruiting
Obesity
Not yet recruitingInvestigational
KAI-9531 in Adults With Obesity or Overweight and Diabetes
Investigational
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:HRS 9531
Back to PolandClinical trials in Zamosc – page 4
93 clinical trials in Zamosc, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Zamosc at a glance
93
clinical trials
- Paediatric trials0
- Research sites1
Not yet recruiting
Psoriatic arthropathy
Not yet recruitingInvestigationalNo placebo
A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis
InvestigationalNo placebo
- Disease:Psoriatic arthropathy
- Substances:Sonelokimab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Sonelokimab
- Sponsor:MoonLake Immunotherapeutics AG
Not yet recruiting
Arteriosclerosis
Not yet recruitingInvestigational
Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Not yet recruiting
Metapneumovirus infection
Not yet recruitingInvestigational
Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
Investigational
- Disease:Metapneumovirus infection
- Substances:HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
Countries:Poland
Poland- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:HUMAN METAPNEUMOVIRUS, VIRUS-LIKE PROTEIN
- Sponsor:AstraZeneca AB
Not yet recruiting
Crohn's disease
Not yet recruitingInvestigational
Efficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
Investigational
- Disease:Crohn's disease
- Substances:ORG-129
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:ORG-129
- Sponsor:Agomab Spain S.L.U.
Not yet recruiting
Coronary artery disease
Not yet recruitingInvestigational
Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease
Investigational
- Disease:Coronary artery disease
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Sponsor:Ribocure Pharmaceuticals AB
Not yet recruiting
Rheumatoid arthritis
Not yet recruitingRegistered drugNo placebo
Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
Registered drugNo placebo
- Disease:Rheumatoid arthritis
- Substances:Etanercept
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Etanercept
- Sponsor:Mabxience Research S.L.
Not yet recruiting
Colitis ulcerative
Not yet recruitingInvestigational
Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
Investigational
- Disease:Colitis ulcerative
- Substances:Obefazimod
Countries:Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Obefazimod
- Sponsor:Abivax
Not yet recruiting
Colitis ulcerative
Not yet recruitingInvestigational
Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
Investigational
- Disease:Colitis ulcerative
- Substances:Obefazimod
Countries:Poland
Poland- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Obefazimod
- Sponsor:Abivax
Not recruiting
Gastrooesophageal reflux disease+1
Not recruitingRegistered drug
Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
Registered drug
- Disease:Gastrooesophageal reflux diseaseErosive oesophagitis
- Substances:LansoprazoleLINAPRAZAN GLURATE
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Lansoprazole
- Sponsor:Cinclus Pharma Holding AB (publ)
Not recruiting
Arteriosclerosis
Not recruitingInvestigational
A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
Investigational
- Disease:Arteriosclerosis
- Substances:–
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Sponsor:Amgen Inc.
Not recruiting
Cardiovascular disorder
Not recruitingInvestigational
A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
Investigational
- Disease:Cardiovascular disorder
- Substances:CagrilintideSemaglutide
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Cagrilintide
- Sponsor:Novo Nordisk A/S
Other cities in Poland
The busiest research cities in the country
Clinical research in Zamosc
What the registry says about research in the country
01 Respiratory Research
Innovative trials focusing on respiratory infections and prevention strategies, including studies of vaccines against RSV and influenza in older adults.
- Respiratory Syncytial Virus (RSV)
- Human Metapneumovirus (hMPV)
- Influenza Prevention
These studies aim to enhance protection against common respiratory illnesses in vulnerable populations.
02 Gastrointestinal Studies
Comprehensive research into inflammatory bowel conditions, with multiple trials examining new treatments for Crohn's Disease and Ulcerative Colitis.
- Moderate to Severe Ulcerative Colitis
- Fibrostenotic Crohn's Disease
- Novel Therapeutic Approaches
Investigations focus on both established and experimental treatments to improve disease management.
03 Cardiovascular Research
Advanced studies targeting atherosclerotic cardiovascular disease and stroke prevention in patients with atrial fibrillation.
- Stroke Prevention
- Atherosclerosis Management
- Cardiovascular Risk Reduction
Trials evaluate innovative treatments to reduce major adverse cardiovascular events.